Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Envoy Medical (COCH) Non-cash Items (2024)

Envoy Medical's Non-cash Items history spans 1 years, with the latest figure at $5.0 million for Q4 2024.

On a quarterly basis, Non-cash Items changed N/A to $5.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was $5.0 million, a N/A change, with the full-year FY2024 number at $5.0 million, changed N/A from a year prior.
Non-cash Items hit $5.0 million in Q4 2024 for Envoy Medical, down from $1.9 billion in the prior quarter.
Over the last five years, Non-cash Items for COCH hit a ceiling of $3.1 billion in Q1 2024 and a floor of $962082.0 in Q2 2024.